Virtual therapy may ease breast cancer treatment side effects

NCT ID NCT07759947

Not yet recruiting Symptom relief Sponsor: Massachusetts General Hospital Source: ClinicalTrials.gov ↗

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This study tests a 6-session telehealth program called STRIDE, which uses cognitive behavioral therapy to help women with hormone-positive breast cancer manage side effects from adjuvant endocrine therapy. Participants will be randomly assigned to either the STRIDE program or usual care. The goal is to see if the program improves coping skills and helps women stay on their medication.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: STRIDE, a 6-session cognitive behavioral therapy-based telehealth program
What this could lead to: If effective, this program could offer a practical way to help breast cancer survivors manage side effects and stick with their hormone therapy, potentially improving quality of life and treatment outcomes.
What could go wrong: This is a behavioral intervention, so benefits may vary. The trial is not a drug test, and results depend on participants' engagement and the program's delivery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HORMONE RECEPTOR POSITIVE BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hormone receptor-positive breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HORMONE RECEPTOR POSITIVE BREAST CANCER

Contacts and locations

Locations

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States
Moffitt Cancer Center

Tampa, Florida, 33612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.